 | • レポートコード：MRC2-11QY12985 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は静脈血栓塞栓症治療薬のグローバル市場について調査・分析したレポートです。種類別（ヘパリン、アピキサバン、ダビガトラン、リバロキサバン、エダクサバン、ワルファリン）市場規模、用途別（病院、診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別静脈血栓塞栓症治療薬の競争状況、市場シェア ・世界の静脈血栓塞栓症治療薬市場：種類別市場規模 2015年-2020年（ヘパリン、アピキサバン、ダビガトラン、リバロキサバン、エダクサバン、ワルファリン） ・世界の静脈血栓塞栓症治療薬市場：種類別市場規模予測 2021年-2026年（ヘパリン、アピキサバン、ダビガトラン、リバロキサバン、エダクサバン、ワルファリン） ・世界の静脈血栓塞栓症治療薬市場：用途別市場規模 2015年-2020年（病院、診療所） ・世界の静脈血栓塞栓症治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所） ・北米の静脈血栓塞栓症治療薬市場分析：米国、カナダ ・ヨーロッパの静脈血栓塞栓症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの静脈血栓塞栓症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の静脈血栓塞栓症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの静脈血栓塞栓症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、BMS、Boehringer Ingelheim、Daiichi Sankyo、Johnson & Johnson、Sanofi、Altor Bioscience、Armetheon、Aspen Pharma、BioInvent、eXIthera Pharmaceuticals、Gamma Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Venous Thromboembolism Therapeutics Drugs Market
The global Venous Thromboembolism Therapeutics Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Venous Thromboembolism Therapeutics Drugs Scope and Market Size
Venous Thromboembolism Therapeutics Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Venous Thromboembolism Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Venous Thromboembolism Therapeutics Drugs market is segmented into
Heparin
Apixaban
Dabigatran
Rivaroxaban
Edaxaban
Warfarin
Segment by Application, the Venous Thromboembolism Therapeutics Drugs market is segmented into
Hospital
Clinic
Regional and Country-level Analysis
The Venous Thromboembolism Therapeutics Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Venous Thromboembolism Therapeutics Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Venous Thromboembolism Therapeutics Drugs Market Share Analysis
Venous Thromboembolism Therapeutics Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Venous Thromboembolism Therapeutics Drugs business, the date to enter into the Venous Thromboembolism Therapeutics Drugs market, Venous Thromboembolism Therapeutics Drugs product introduction, recent developments, etc.
The major vendors covered:
Bayer
BMS
Boehringer Ingelheim
Daiichi Sankyo
Johnson & Johnson
Sanofi
Altor Bioscience
Armetheon
Aspen Pharma
BioInvent
eXIthera Pharmaceuticals
Gamma Therapeutics
1 Study Coverage
1.1 Venous Thromboembolism Therapeutics Drugs Product Introduction
1.2 Market Segments
1.3 Key Venous Thromboembolism Therapeutics Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Venous Thromboembolism Therapeutics Drugs Market Size Growth Rate by Type
1.4.2 Heparin
1.4.3 Apixaban
1.4.4 Dabigatran
1.4.5 Rivaroxaban
1.4.6 Edaxaban
1.4.7 Warfarin
1.5 Market by Application
1.5.1 Global Venous Thromboembolism Therapeutics Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Venous Thromboembolism Therapeutics Drugs Market Size, Estimates and Forecasts
2.1.1 Global Venous Thromboembolism Therapeutics Drugs Revenue 2015-2026
2.1.2 Global Venous Thromboembolism Therapeutics Drugs Sales 2015-2026
2.2 Global Venous Thromboembolism Therapeutics Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Venous Thromboembolism Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Venous Thromboembolism Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Venous Thromboembolism Therapeutics Drugs Competitor Landscape by Players
3.1 Venous Thromboembolism Therapeutics Drugs Sales by Manufacturers
3.1.1 Venous Thromboembolism Therapeutics Drugs Sales by Manufacturers (2015-2020)
3.1.2 Venous Thromboembolism Therapeutics Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Venous Thromboembolism Therapeutics Drugs Revenue by Manufacturers
3.2.1 Venous Thromboembolism Therapeutics Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Venous Thromboembolism Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Venous Thromboembolism Therapeutics Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Venous Thromboembolism Therapeutics Drugs Revenue in 2019
3.2.5 Global Venous Thromboembolism Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Venous Thromboembolism Therapeutics Drugs Price by Manufacturers
3.4 Venous Thromboembolism Therapeutics Drugs Manufacturing Base Distribution, Product Types
3.4.1 Venous Thromboembolism Therapeutics Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Venous Thromboembolism Therapeutics Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Venous Thromboembolism Therapeutics Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Venous Thromboembolism Therapeutics Drugs Market Size by Type (2015-2020)
4.1.1 Global Venous Thromboembolism Therapeutics Drugs Sales by Type (2015-2020)
4.1.2 Global Venous Thromboembolism Therapeutics Drugs Revenue by Type (2015-2020)
4.1.3 Venous Thromboembolism Therapeutics Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Venous Thromboembolism Therapeutics Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Venous Thromboembolism Therapeutics Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Venous Thromboembolism Therapeutics Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Venous Thromboembolism Therapeutics Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Venous Thromboembolism Therapeutics Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Venous Thromboembolism Therapeutics Drugs Market Size by Application (2015-2020)
5.1.1 Global Venous Thromboembolism Therapeutics Drugs Sales by Application (2015-2020)
5.1.2 Global Venous Thromboembolism Therapeutics Drugs Revenue by Application (2015-2020)
5.1.3 Venous Thromboembolism Therapeutics Drugs Price by Application (2015-2020)
5.2 Venous Thromboembolism Therapeutics Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Venous Thromboembolism Therapeutics Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Venous Thromboembolism Therapeutics Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Venous Thromboembolism Therapeutics Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Venous Thromboembolism Therapeutics Drugs by Country
6.1.1 North America Venous Thromboembolism Therapeutics Drugs Sales by Country
6.1.2 North America Venous Thromboembolism Therapeutics Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Venous Thromboembolism Therapeutics Drugs Market Facts & Figures by Type
6.3 North America Venous Thromboembolism Therapeutics Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Venous Thromboembolism Therapeutics Drugs by Country
7.1.1 Europe Venous Thromboembolism Therapeutics Drugs Sales by Country
7.1.2 Europe Venous Thromboembolism Therapeutics Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Venous Thromboembolism Therapeutics Drugs Market Facts & Figures by Type
7.3 Europe Venous Thromboembolism Therapeutics Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Venous Thromboembolism Therapeutics Drugs by Region
8.1.1 Asia Pacific Venous Thromboembolism Therapeutics Drugs Sales by Region
8.1.2 Asia Pacific Venous Thromboembolism Therapeutics Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Venous Thromboembolism Therapeutics Drugs Market Facts & Figures by Type
8.3 Asia Pacific Venous Thromboembolism Therapeutics Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Venous Thromboembolism Therapeutics Drugs by Country
9.1.1 Latin America Venous Thromboembolism Therapeutics Drugs Sales by Country
9.1.2 Latin America Venous Thromboembolism Therapeutics Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Venous Thromboembolism Therapeutics Drugs Market Facts & Figures by Type
9.3 Central & South America Venous Thromboembolism Therapeutics Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Venous Thromboembolism Therapeutics Drugs by Country
10.1.1 Middle East and Africa Venous Thromboembolism Therapeutics Drugs Sales by Country
10.1.2 Middle East and Africa Venous Thromboembolism Therapeutics Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Venous Thromboembolism Therapeutics Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Venous Thromboembolism Therapeutics Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Venous Thromboembolism Therapeutics Drugs Products Offered
11.1.5 Bayer Related Developments
11.2 BMS
11.2.1 BMS Corporation Information
11.2.2 BMS Description and Business Overview
11.2.3 BMS Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BMS Venous Thromboembolism Therapeutics Drugs Products Offered
11.2.5 BMS Related Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Description and Business Overview
11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Venous Thromboembolism Therapeutics Drugs Products Offered
11.3.5 Boehringer Ingelheim Related Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Corporation Information
11.4.2 Daiichi Sankyo Description and Business Overview
11.4.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Daiichi Sankyo Venous Thromboembolism Therapeutics Drugs Products Offered
11.4.5 Daiichi Sankyo Related Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description and Business Overview
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson Venous Thromboembolism Therapeutics Drugs Products Offered
11.5.5 Johnson & Johnson Related Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description and Business Overview
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Venous Thromboembolism Therapeutics Drugs Products Offered
11.6.5 Sanofi Related Developments
11.7 Altor Bioscience
11.7.1 Altor Bioscience Corporation Information
11.7.2 Altor Bioscience Description and Business Overview
11.7.3 Altor Bioscience Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Altor Bioscience Venous Thromboembolism Therapeutics Drugs Products Offered
11.7.5 Altor Bioscience Related Developments
11.8 Armetheon
11.8.1 Armetheon Corporation Information
11.8.2 Armetheon Description and Business Overview
11.8.3 Armetheon Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Armetheon Venous Thromboembolism Therapeutics Drugs Products Offered
11.8.5 Armetheon Related Developments
11.9 Aspen Pharma
11.9.1 Aspen Pharma Corporation Information
11.9.2 Aspen Pharma Description and Business Overview
11.9.3 Aspen Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Aspen Pharma Venous Thromboembolism Therapeutics Drugs Products Offered
11.9.5 Aspen Pharma Related Developments
11.10 BioInvent
11.10.1 BioInvent Corporation Information
11.10.2 BioInvent Description and Business Overview
11.10.3 BioInvent Sales, Revenue and Gross Margin (2015-2020)
11.10.4 BioInvent Venous Thromboembolism Therapeutics Drugs Products Offered
11.10.5 BioInvent Related Developments
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Venous Thromboembolism Therapeutics Drugs Products Offered
11.1.5 Bayer Related Developments
11.12 Gamma Therapeutics
11.12.1 Gamma Therapeutics Corporation Information
11.12.2 Gamma Therapeutics Description and Business Overview
11.12.3 Gamma Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Gamma Therapeutics Products Offered
11.12.5 Gamma Therapeutics Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Venous Thromboembolism Therapeutics Drugs Market Estimates and Projections by Region
12.1.1 Global Venous Thromboembolism Therapeutics Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Venous Thromboembolism Therapeutics Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Venous Thromboembolism Therapeutics Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Venous Thromboembolism Therapeutics Drugs Sales Forecast (2021-2026)
12.2.2 North America: Venous Thromboembolism Therapeutics Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Venous Thromboembolism Therapeutics Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Venous Thromboembolism Therapeutics Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Venous Thromboembolism Therapeutics Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Venous Thromboembolism Therapeutics Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Venous Thromboembolism Therapeutics Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Venous Thromboembolism Therapeutics Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Venous Thromboembolism Therapeutics Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Venous Thromboembolism Therapeutics Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Venous Thromboembolism Therapeutics Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Venous Thromboembolism Therapeutics Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Venous Thromboembolism Therapeutics Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Venous Thromboembolism Therapeutics Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Venous Thromboembolism Therapeutics Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Venous Thromboembolism Therapeutics Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Venous Thromboembolism Therapeutics Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Venous Thromboembolism Therapeutics Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Venous Thromboembolism Therapeutics Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Venous Thromboembolism Therapeutics Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Venous Thromboembolism Therapeutics Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Venous Thromboembolism Therapeutics Drugs Market Segments
Table 2. Ranking of Global Top Venous Thromboembolism Therapeutics Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Venous Thromboembolism Therapeutics Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Heparin
Table 5. Major Manufacturers of Apixaban
Table 6. Major Manufacturers of Dabigatran
Table 7. Major Manufacturers of Rivaroxaban
Table 8. Major Manufacturers of Edaxaban
Table 9. Major Manufacturers of Warfarin
Table 10. Global Venous Thromboembolism Therapeutics Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Venous Thromboembolism Therapeutics Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Venous Thromboembolism Therapeutics Drugs Sales by Regions 2015-2020 (K Units)
Table 13. Global Venous Thromboembolism Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Venous Thromboembolism Therapeutics Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Venous Thromboembolism Therapeutics Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Venous Thromboembolism Therapeutics Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Venous Thromboembolism Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Venous Thromboembolism Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Venous Thromboembolism Therapeutics Drugs as of 2019)
Table 19. Venous Thromboembolism Therapeutics Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Venous Thromboembolism Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Venous Thromboembolism Therapeutics Drugs Price (2015-2020) (US$/Unit)
Table 22. Venous Thromboembolism Therapeutics Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Venous Thromboembolism Therapeutics Drugs Product Type
Table 24. Date of International Manufacturers Enter into Venous Thromboembolism Therapeutics Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Venous Thromboembolism Therapeutics Drugs Sales by Type (2015-2020) (K Units)
Table 27. Global Venous Thromboembolism Therapeutics Drugs Sales Share by Type (2015-2020)
Table 28. Global Venous Thromboembolism Therapeutics Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Venous Thromboembolism Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 30. Venous Thromboembolism Therapeutics Drugs Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)
Table 31. Global Venous Thromboembolism Therapeutics Drugs Sales by Application (2015-2020) (K Units)
Table 32. Global Venous Thromboembolism Therapeutics Drugs Sales Share by Application (2015-2020)
Table 33. North America Venous Thromboembolism Therapeutics Drugs Sales by Country (2015-2020) (K Units)
Table 34. North America Venous Thromboembolism Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 35. North America Venous Thromboembolism Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 37. North America Venous Thromboembolism Therapeutics Drugs Sales by Type (2015-2020) (K Units)
Table 38. North America Venous Thromboembolism Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 39. North America Venous Thromboembolism Therapeutics Drugs Sales by Application (2015-2020) (K Units)
Table 40. North America Venous Thromboembolism Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 41. Europe Venous Thromboembolism Therapeutics Drugs Sales by Country (2015-2020) (K Units)
Table 42. Europe Venous Thromboembolism Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 43. Europe Venous Thromboembolism Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 45. Europe Venous Thromboembolism Therapeutics Drugs Sales by Type (2015-2020) (K Units)
Table 46. Europe Venous Thromboembolism Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 47. Europe Venous Thromboembolism Therapeutics Drugs Sales by Application (2015-2020) (K Units)
Table 48. Europe Venous Thromboembolism Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Venous Thromboembolism Therapeutics Drugs Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Venous Thromboembolism Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Venous Thromboembolism Therapeutics Drugs Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Venous Thromboembolism Therapeutics Drugs Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Venous Thromboembolism Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Venous Thromboembolism Therapeutics Drugs Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Venous Thromboembolism Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 57. Latin America Venous Thromboembolism Therapeutics Drugs Sales by Country (2015-2020) (K Units)
Table 58. Latin America Venous Thromboembolism Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Venous Thromboembolism Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 61. Latin America Venous Thromboembolism Therapeutics Drugs Sales by Type (2015-2020) (K Units)
Table 62. Latin America Venous Thromboembolism Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 63. Latin America Venous Thromboembolism Therapeutics Drugs Sales by Application (2015-2020) (K Units)
Table 64. Latin America Venous Thromboembolism Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 73. Bayer Corporation Information
Table 74. Bayer Description and Major Businesses
Table 75. Bayer Venous Thromboembolism Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Bayer Product
Table 77. Bayer Recent Development
Table 78. BMS Corporation Information
Table 79. BMS Description and Major Businesses
Table 80. BMS Venous Thromboembolism Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. BMS Product
Table 82. BMS Recent Development
Table 83. Boehringer Ingelheim Corporation Information
Table 84. Boehringer Ingelheim Description and Major Businesses
Table 85. Boehringer Ingelheim Venous Thromboembolism Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Boehringer Ingelheim Product
Table 87. Boehringer Ingelheim Recent Development
Table 88. Daiichi Sankyo Corporation Information
Table 89. Daiichi Sankyo Description and Major Businesses
Table 90. Daiichi Sankyo Venous Thromboembolism Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Daiichi Sankyo Product
Table 92. Daiichi Sankyo Recent Development
Table 93. Johnson & Johnson Corporation Information
Table 94. Johnson & Johnson Description and Major Businesses
Table 95. Johnson & Johnson Venous Thromboembolism Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Johnson & Johnson Product
Table 97. Johnson & Johnson Recent Development
Table 98. Sanofi Corporation Information
Table 99. Sanofi Description and Major Businesses
Table 100. Sanofi Venous Thromboembolism Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Sanofi Product
Table 102. Sanofi Recent Development
Table 103. Altor Bioscience Corporation Information
Table 104. Altor Bioscience Description and Major Businesses
Table 105. Altor Bioscience Venous Thromboembolism Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Altor Bioscience Product
Table 107. Altor Bioscience Recent Development
Table 108. Armetheon Corporation Information
Table 109. Armetheon Description and Major Businesses
Table 110. Armetheon Venous Thromboembolism Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 111. Armetheon Product
Table 112. Armetheon Recent Development
Table 113. Aspen Pharma Corporation Information
Table 114. Aspen Pharma Description and Major Businesses
Table 115. Aspen Pharma Venous Thromboembolism Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 116. Aspen Pharma Product
Table 117. Aspen Pharma Recent Development
Table 118. BioInvent Corporation Information
Table 119. BioInvent Description and Major Businesses
Table 120. BioInvent Venous Thromboembolism Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 121. BioInvent Product
Table 122. BioInvent Recent Development
Table 123. eXIthera Pharmaceuticals Corporation Information
Table 124. eXIthera Pharmaceuticals Description and Major Businesses
Table 125. eXIthera Pharmaceuticals Venous Thromboembolism Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 126. eXIthera Pharmaceuticals Product
Table 127. eXIthera Pharmaceuticals Recent Development
Table 128. Gamma Therapeutics Corporation Information
Table 129. Gamma Therapeutics Description and Major Businesses
Table 130. Gamma Therapeutics Venous Thromboembolism Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 131. Gamma Therapeutics Product
Table 132. Gamma Therapeutics Recent Development
Table 133. Global Venous Thromboembolism Therapeutics Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 134. Global Venous Thromboembolism Therapeutics Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 135. Global Venous Thromboembolism Therapeutics Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 136. Global Venous Thromboembolism Therapeutics Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 137. North America: Venous Thromboembolism Therapeutics Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 138. North America: Venous Thromboembolism Therapeutics Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Europe: Venous Thromboembolism Therapeutics Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 140. Europe: Venous Thromboembolism Therapeutics Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Asia Pacific: Venous Thromboembolism Therapeutics Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 142. Asia Pacific: Venous Thromboembolism Therapeutics Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 143. Latin America: Venous Thromboembolism Therapeutics Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 144. Latin America: Venous Thromboembolism Therapeutics Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Middle East and Africa: Venous Thromboembolism Therapeutics Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 146. Middle East and Africa: Venous Thromboembolism Therapeutics Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 148. Key Challenges
Table 149. Market Risks
Table 150. Main Points Interviewed from Key Venous Thromboembolism Therapeutics Drugs Players
Table 151. Venous Thromboembolism Therapeutics Drugs Customers List
Table 152. Venous Thromboembolism Therapeutics Drugs Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Venous Thromboembolism Therapeutics Drugs Product Picture
Figure 2. Global Venous Thromboembolism Therapeutics Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Heparin Product Picture
Figure 4. Apixaban Product Picture
Figure 5. Dabigatran Product Picture
Figure 6. Rivaroxaban Product Picture
Figure 7. Edaxaban Product Picture
Figure 8. Warfarin Product Picture
Figure 9. Global Venous Thromboembolism Therapeutics Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Venous Thromboembolism Therapeutics Drugs Report Years Considered
Figure 13. Global Venous Thromboembolism Therapeutics Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Venous Thromboembolism Therapeutics Drugs Sales 2015-2026 (K Units)
Figure 15. Global Venous Thromboembolism Therapeutics Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Venous Thromboembolism Therapeutics Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Venous Thromboembolism Therapeutics Drugs Sales Market Share by Region in 2019
Figure 18. Global Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 20. Global Venous Thromboembolism Therapeutics Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Venous Thromboembolism Therapeutics Drugs Revenue in 2019
Figure 22. Venous Thromboembolism Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Venous Thromboembolism Therapeutics Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Venous Thromboembolism Therapeutics Drugs Sales Market Share by Type in 2019
Figure 25. Global Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Type in 2019
Figure 27. Global Venous Thromboembolism Therapeutics Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Venous Thromboembolism Therapeutics Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Venous Thromboembolism Therapeutics Drugs Sales Market Share by Application in 2019
Figure 30. Global Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Application in 2019
Figure 32. North America Venous Thromboembolism Therapeutics Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Venous Thromboembolism Therapeutics Drugs Sales Market Share by Country in 2019
Figure 35. North America Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Venous Thromboembolism Therapeutics Drugs Market Share by Type in 2019
Figure 41. North America Venous Thromboembolism Therapeutics Drugs Market Share by Application in 2019
Figure 42. Europe Venous Thromboembolism Therapeutics Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Venous Thromboembolism Therapeutics Drugs Sales Market Share by Country in 2019
Figure 45. Europe Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Venous Thromboembolism Therapeutics Drugs Market Share by Type in 2019
Figure 57. Europe Venous Thromboembolism Therapeutics Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Venous Thromboembolism Therapeutics Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Venous Thromboembolism Therapeutics Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 62. China Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Venous Thromboembolism Therapeutics Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Venous Thromboembolism Therapeutics Drugs Market Share by Application in 2019
Figure 86. Latin America Venous Thromboembolism Therapeutics Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Venous Thromboembolism Therapeutics Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Venous Thromboembolism Therapeutics Drugs Market Share by Type in 2019
Figure 97. Latin America Venous Thromboembolism Therapeutics Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. UAE Venous Thromboembolism Therapeutics Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. UAE Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Market Share by Application in 2019
Figure 110. North America Venous Thromboembolism Therapeutics Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Venous Thromboembolism Therapeutics Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Venous Thromboembolism Therapeutics Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Venous Thromboembolism Therapeutics Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Venous Thromboembolism Therapeutics Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
静脈血栓塞栓症（VTE）治療薬の世界市場（～2026年） Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual (Heit, 2015). In VTE, a DVT is a clot tha…- 静脈性下肢潰瘍治療の世界市場（～2026年） Market Analysis and Insights: Global Venous Leg Ulcers Treatment Market The global Venous Leg Ulcers Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Venous Leg Ulcers Treatment Scope and Market Size Venous Le…
- 静脈-静脈ECMOシステムの世界市場（～2026年） Market Analysis and Insights: Global Veno-Venous ECMO System Market The global Veno-Venous ECMO System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veno-Venous ECMO System Scope and Market Size Veno-Venous ECMO Syst…
- 頭頸部がん治療薬/治療の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…
- 生物学的治療薬の世界市場（～2026年） Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural s…